The necessity, efficacy and safety of biologics in juvenile idiopathic arthritis

Cakan M., Ayaz N., Karadag Ş. G., Tanatar A.

NORTHERN CLINICS OF ISTANBUL, vol.7, no.2, pp.118-123, 2020 (ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 7 Issue: 2
  • Publication Date: 2020
  • Doi Number: 10.14744/nci.2019.57873
  • Journal Name: NORTHERN CLINICS OF ISTANBUL
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.118-123
  • Keywords: Biologics, juvenile idiopathic arthritis, tuberculosis, LATENT TUBERCULOSIS INFECTION, SKIN-TEST, CHILDREN, METHOTREXATE, RATES, RISK
  • Istanbul University Affiliated: Yes

Abstract

OBJECTIVE: Juvenile idiopathic arthritis (JIA) is the most common cause of chronic arthritis in children. Biologics have changed the faith of children with rheumatic diseases. The main objective of this study was to demonstrate the rate of usage, efficacy and safety of biologics in JIA subtypes.